Study proposes new system for understanding and evaluating PrEP implementation in clinical practice

February 15, 2017

PROVIDENCE, R.I. [Brown University] — One of the most promising new approaches to slowing the spread of HIV is pre-exposure prophylaxis (PrEP), a once-a-day medication that people who don’t have HIV can take to prevent becoming infected. But that strategy only works if people at risk for contracting HIV become and remain fully engaged in preventive care and actually take the pills. In the real world of clinical practice, that has often proved tricky. READ MORE